Premium
Primary cutaneous marginal zone lymphoma treated with doxycycline in a pediatric patient
Author(s) -
Jothishankar Balaji,
Di Raimondo Cosimo,
Mueller Lisa,
Zain Jasmine,
Parekh Vishwas,
Abdulla Farah
Publication year - 2020
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.14165
Subject(s) - doxycycline , medicine , asymptomatic , dermatology , borrelia burgdorferi , lymphoma , biopsy , surgery , pathology , immunology , antibiotics , antibody , microbiology and biotechnology , biology
Abstract We present the third reported case of a primary cutaneous marginal zone lymphoma (PCMZL) treated with doxycycline in a pediatric patient with negative serology for Borrelia burgdorferi . A 14‐year‐old boy presented with multiple asymptomatic erythematous papules and nodules on his extremities and trunk which biopsy confirmed to be PCMZL. He was started on doxycycline and experienced a near‐complete response. Given the favorable side effect profile of doxycycline and the indolent nature of PCMZL, we believe doxycycline is a possible therapy for PCMZL pediatric patients who have widely disseminated cutaneous disease.